Melissa Baird - Dec 29, 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Chief Operating Officer
Signature: /s/ Carly Larson, Attorney-in-Fact
Stock symbol: HIMS
Transactions as of: Dec 29, 2023
Transactions value $: $186,999
Form type: 4
Date filed: 1/3/2024, 04:40 PM
Previous filing: Dec 19, 2023
Next filing: Mar 1, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Options Exercise	$100K	+57.3K	+13.83%	$1.75	472K	Dec 29, 2023	Direct
transaction	HIMS	Class A Common Stock	Options Exercise	$86.7K	+35.7K	+7.56%	$2.43	507K	Dec 29, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-57.3K	-50.63%	$0.00	55.9K	Dec 29, 2023	Class A Common Stock	57.3K	$1.75	Direct	F1
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-35.7K	-4.58%	$0.00	743K	Dec 29, 2023	Class A Common Stock	35.7K	$2.43	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
F2	Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. The shares subject to the option will be fully vested on February 12, 2024, subject to the Reporting Person's continuous service. The option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

Content

Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. The shares subject to the option will be fully vested on February 12, 2024, subject to the Reporting Person's continuous service. The option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).